Affordable drug resistance genotyping of HIV-1 reverse transcriptase, protease and integrase genes, for resource limited settings
Abstract Background As use of dolutegravir (DTG) becomes more common in resource limited settings (RLS), the demand for integrase resistance testing is increasing. Affordable methods for genotyping all relevant HIV-1 pol genes (i.e., protease (PR), reverse transcriptase (RT) and integrase (IN)) are...
Main Authors: | Sontaga Manyana, Melendhran Pillay, Lilishia Gounder, Aabida Khan, Pravi Moodley, Kogieleum Naidoo, Benjamin Chimukangara |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | AIDS Research and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12981-023-00505-3 |
Similar Items
-
HIV-1 Drug Resistance Genotyping in Resource Limited Settings: Current and Future Perspectives in Sequencing Technologies
by: Sontaga Manyana, et al.
Published: (2021-06-01) -
Identification of HIV-1 subtype CRF18_cpx in a patient with multidrug resistance in KwaZulu-Natal, South Africa: An epidemiological worry?
by: Aabida Khan, et al.
Published: (2023-06-01) -
<i>Cis</i>-Allosteric Regulation of HIV-1 Reverse Transcriptase by Integrase
by: Takao Masuda, et al.
Published: (2022-12-01) -
Coevolved Multidrug-Resistant HIV-1 Protease and Reverse Transcriptase Influences Integrase Drug Susceptibility and Replication Fitness
by: Supang A. Martin, et al.
Published: (2021-08-01) -
The Occurrence of Integrase Genes in Different Stages of Wastewater Treatment
by: Martyna Buta, et al.
Published: (2019-11-01)